These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 10804015

  • 1. In vivo demonstration that human parathyroid hormone 1-38 inhibits the expression of osteoprotegerin in bone with the kinetics of an immediate early gene.
    Onyia JE, Miles RR, Yang X, Halladay DL, Hale J, Glasebrook A, McClure D, Seno G, Churgay L, Chandrasekhar S, Martin TJ.
    J Bone Miner Res; 2000 May; 15(5):863-71. PubMed ID: 10804015
    [Abstract] [Full Text] [Related]

  • 2. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells.
    Kondo H, Guo J, Bringhurst FR.
    J Bone Miner Res; 2002 Sep; 17(9):1667-79. PubMed ID: 12211438
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Analysis of signaling pathways used by parathyroid hormone to activate the c-fos gene in human SaOS2 osteoblast-like cells.
    Evans DB, Hipskind RA, Bilbe G.
    J Bone Miner Res; 1996 Aug; 11(8):1066-74. PubMed ID: 8854242
    [Abstract] [Full Text] [Related]

  • 10. SOST is a target gene for PTH in bone.
    Keller H, Kneissel M.
    Bone; 2005 Aug; 37(2):148-58. PubMed ID: 15946907
    [Abstract] [Full Text] [Related]

  • 11. Regulation of receptor activator of nuclear factor-kappa B ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase a pathway in murine bone marrow cultures.
    Lee SK, Lorenzo JA.
    Bone; 2002 Jul; 31(1):252-9. PubMed ID: 12110442
    [Abstract] [Full Text] [Related]

  • 12. In vivo administration of 1,25-dihydroxyvitamin D3 suppresses the expression of RANKL mRNA in bone of thyroparathyroidectomized rats constantly infused with PTH.
    Ueno Y, Shinki T, Nagai Y, Murayama H, Fujii K, Suda T.
    J Cell Biochem; 2003 Oct 01; 90(2):267-77. PubMed ID: 14505343
    [Abstract] [Full Text] [Related]

  • 13. Identification of signal transduction pathways and promoter sequences that mediate parathyroid hormone 1-38 inhibition of osteoprotegerin gene expression.
    Halladay DL, Miles RR, Thirunavukkarasu K, Chandrasekhar S, Martin TJ, Onyia JE.
    J Cell Biochem; 2001 Oct 01; 84(1):1-11. PubMed ID: 11746511
    [Abstract] [Full Text] [Related]

  • 14. Second messenger signaling of c-fos gene induction by parathyroid hormone (PTH) and PTH-related peptide in osteoblastic osteosarcoma cells: its role in osteoblast proliferation and osteoclast-like cell formation.
    Kano J, Sugimoto T, Kanatani M, Kuroki Y, Tsukamoto T, Fukase M, Chihara K.
    J Cell Physiol; 1994 Nov 01; 161(2):358-66. PubMed ID: 7962120
    [Abstract] [Full Text] [Related]

  • 15. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
    Kanatani M, Sugimoto T, Kano J, Kanzawa M, Chihara K.
    J Cell Physiol; 2003 Jul 01; 196(1):180-9. PubMed ID: 12767054
    [Abstract] [Full Text] [Related]

  • 16. Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-kappab ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism.
    Stilgren LS, Rettmer E, Eriksen EF, Hegedüs L, Beck-Nielsen H, Abrahamsen B.
    Bone; 2004 Jul 01; 35(1):256-65. PubMed ID: 15207766
    [Abstract] [Full Text] [Related]

  • 17. Unmasking the osteoinductive effects of a G-protein-coupled receptor (GPCR) kinase (GRK) inhibitor by treatment with PTH(1-34).
    Wang L, Quarles LD, Spurney RF.
    J Bone Miner Res; 2004 Oct 01; 19(10):1661-70. PubMed ID: 15355561
    [Abstract] [Full Text] [Related]

  • 18. Osteoprotegerin mRNA is increased by interleukin-1 alpha in the human osteosarcoma cell line MG-63 and in human osteoblast-like cells.
    Vidal ON, Sjögren K, Eriksson BI, Ljunggren O, Ohlsson C.
    Biochem Biophys Res Commun; 1998 Jul 30; 248(3):696-700. PubMed ID: 9703989
    [Abstract] [Full Text] [Related]

  • 19. Parathyroid hormone (hPTH 1-38) stimulates the expression of UBP41, an ubiquitin-specific protease, in bone.
    Miles RR, Sluka JP, Halladay DL, Santerre RF, Hale LV, Bloem L, Patanjali SR, Galvin RJ, Ma L, Hock JM, Onyia JE.
    J Cell Biochem; 2002 Jul 30; 85(2):229-42. PubMed ID: 11948679
    [Abstract] [Full Text] [Related]

  • 20. Transforming growth factor-beta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells.
    Murakami T, Yamamoto M, Ono K, Nishikawa M, Nagata N, Motoyoshi K, Akatsu T.
    Biochem Biophys Res Commun; 1998 Nov 27; 252(3):747-52. PubMed ID: 9837778
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.